Fortress Biotech, Inc. (FBIO)
$2.13+1.91%Close
SELLCRISIS · day 22
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $71M
- Beta
- 1.19
- P/E (TTM)
- 0.63
- Short % float
- 21.21%
- Days to cover
- 18.4
- SI change
- -4.1%
- 1W
- +4.93%
- 1M
- -17.12%
- vs SPY 1W
- +3.77%
- vs SPY 1M
- -20.11%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on FBIO?
- LOPJLB’s latest quantitative signal on Fortress Biotech, Inc. (FBIO) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is FBIO in?
- Fortress Biotech, Inc. (FBIO) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Fortress Biotech, Inc. (FBIO) do?
- Fortress Biotech, Inc. operates as a biopharmaceutical firm dedicated to the development and commercialization of a diverse range of pharmaceutical and biotechnology products. The company currently offers a portfolio of dermatological treatments. These include Ximino and Targadox, both formulated to address various forms of acne (ranging from moderate-to-severe inflammatory lesions to severe ca…